Figures
Abstract
Glioblastoma tumors form in brains’ white matter and are fast-growing and aggressive. Poor prognosis is the result of therapeutic resistance and infiltrating growth into the surrounding brain. Here we present a protocol for the detection of the cytoskeleton intermediate filament, vimentin, in cells at the proliferating spheroid surface. By combining a classical invasion assay with immunofluorescence and light-sheet imaging, we find that it is exactly these cytoskeleton-reinforcing cells on the spheroid’s surface that will start the infiltration. We anticipate our results to be the starting point of more sophisticated investigation of anti-cancer drug effects on cytoskeleton reorganisation.
Citation: Bjørknes B, Neye OE, Hamerlik P, Jauffred L (2023) Immunostaining protocol for infiltrating brain cancer spheroids for light-sheet imaging. PLoS ONE 18(2): e0281161. https://doi.org/10.1371/journal.pone.0281161
Editor: Michelle R. Dawson, Brown University, UNITED STATES
Received: November 14, 2022; Accepted: January 16, 2023; Published: February 9, 2023
Copyright: © 2023 Bjørknes et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting information files.
Funding: LJ:The Danish National Research Foundation (0165-00032B, 0165-00103B) Danish National Research Councils (DNRF116) Novo Nordisk Foundation (NNF14OC0011361) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Tumor spheroids of primary or xenograft cell lines are well-characterized 3D models of cancer; mimicking essential features of tumors and their micro-environment, such as gradients of oxygen, metabolites, and pH. So when cancer cells grow as spheroids—instead of monolayers—we find an outer proliferating zone, an intermediate quiescent region with limited oxygen and metabolites [1, 2], and occasionally even a necrotic core [3]. This strong cellular and molecular heterogeneity in spheroids makes them adequate models of cancer.
Under normal physiological conditions—when cells are proliferating in tumors—cell-cell adhesion and tissue formation is favored. In contrast, a hallmark of glioblastoma tumors is the infiltrating growth [4], resulting from mesenchymal tumor cells acquiring migrating phenotypes [5, 6].
This phenotypic switch is associated with major rearrangement of the cytoskeleton. For instance in invasive glioblastoma cells, by overexpression of the class III intermediate filament protein vimentin (vim). While vim might not be directly involved in motility, the filaments add mechanical strength through enforcement of the cytoskeleton [7] in invasive phenotypes of both mesenchymal and epithelial cancers [8]. Interestingly, vim expression enforces cell motility even without down-regulating, e.g., cadherins. Thus, indicating that vim expression is sufficient for epithelial cell migration (see Ref. [9] for a review).
Although we understand the gain of invasive traits in individual cells, we can often only guess what the effects will be on larger tumor settings. Therefore, with this protocol we integrate recent advances within 3D primary spheroid culture with the progress of Airy beam light-sheet fluorescence imaging (LSM). We use a combination of nuclear stain and vim antibody marker to show how differently surface-attached human glioblastoma cells (2D) grow, compared to cells in spheroids (3D). Specifically, we find that vim expression is uniform in 2D and limited to the outermost cell-layer of the spheroid in 3D. This is the offset for presenting a protocol for antibody-staining in an invasion assays, which requires staining through the extra-cellular matrix. The expected result, is precise mapping of cytoskeleton markers in infiltrating finger-like protrusions originating from the spheroid surface. We anticipate that the synthesis of these methods can provide us a conceptual model of spatial regulation of invasion to point out new directions to encompass the infiltrating growth of glioblastoma cancers.
Materials and methods
The protocol described in this peer-reviewed article is published on protocols.io, https://dx.doi.org/10.17504/protocols.io.eq2ly77krlx9/v2 and is included for printing as S1 File with this article.
Ethics statement
Glioblastoma (GBM) cell cultures were established from freshly resected tumor tissue including informed consent from each patient, as outlined by the Regional Danish Ethical Committee/Danish Data Protection Agency (H-3–2009-136-63114). Written consent has been acquired from participants whose tissue was used to generate our models. GBM lines were passaged as xenografts in the subcutaneous flank of NOG mice (Taconic, TAC:nog) according to Danish Welfare Law on Animal Experiments Act no 1306, protocol: 2012–15-2934-00636.
Image processing
FIJI [10] was used for initial processing, pseudo-coloring etc. To examine radial distributions of vim and DNA in 3D light-sheet images, the following image was constructed: The spheroid closest surface was identified and a 4 μm thick slice (10 images) in 50 μm into the spheroid was collected. From this slice an average projection was constructed. Then with a custom-build Matlab procedure, the intensity is averaged over all pixels in a ring in a specific radial distance, as detailed in [11] and references therein. This corresponds to averaging over a rotating radial vector, as sketched in the inset of Fig 3. This way, the inside of the spheroid can be studied, as well as the spheroid’s surface. Even though the spheroids are seeded with the same number of cells the size varied, so to compare the expression in spheroids with different sizes, the intensity were plotted from the edge of each spheroid. The resulting arrays of intensities versus spheroid radii was translated into arrays of intensities versus distance from surface, d, to make results independent of size variations. Thus, we define d = 0 to be the point where the nuclear stain (DNA) intensities are falling off most rapidly, i.e., where the magnitude of the time-derivative is the largest. Afterwards, all data is translated accordingly.
Expected results
Our model system is the human glioma xenograft T115 complemented with the primary cell line U87. Through mapping of protein expression, i.e., immunofluorescence, we investigated how glioblastoma cells’ fate depend on spatial organisation. Specifically, we searched for differences in expression levels, when grown in either 2D or 3D configurations.
Surface-attached cells show homogeneous marker expression
After verifying the specificity of our immunological setup (see the Materials and methods for details), we seeded T115 cells in glass-bottom culture dishes and after 3 days of incubation, the cells were fixed and stained with the set of vim antibodies and nuclear stain.
In surface-attached T115, we detected vim (yellow) and cell nuclei (blue), see the upper panel of Fig 1. As the xenograft cell line naturally grow like spheroids when seeded in medium, we anticipate that they attach to the glass surface of the culture dish more loosely. In accordance with our finding that only few cells started to form clusters attached to the surface. So, whilst the staining procedure includes multiple washing, all loosely attached cells has been washed away. Therefore, we suspect that this result favors a sub-population of the highly heterogeneous cell population with specific adherent properties.
Immunofluorescence in parallel assays of vim (yellow) and cell nuclei identified by a nuclear stain (blue) in both GBM xenograft cell line T115 and cell line U87.
The lower panel of Fig 1 shows similar detection in surface-attached U87 cells, in accordance with earlier findings [12] and as expected for this mesenchymal cell type.
Mesenchymal marker expression in 2D
In aim of investigating how geometry affects the expression of mesenchymal markers, we sat up a wound healing (or scratch) assay. In brief, we prepared two patches of surface-attached U87 cell monolayers (as in Fig 1) but separated by a 500 μm gap. Then, after 24 hours of incubation, cells were fixed and stained. We found that U87 cells migrated to close the gap, i.e., healing the wound, as shown in Fig 2. We found that the vim expression level was homogeneous and independent of the distance to the gap in this 2D geometry.
Wound healing experiment in surface-attached U87 brain cancer cells, where the original wound is indicated by the light grey area (GAP). Immunofluorescence parallel assays after 24 hours growth of vim (yellow) and cell nuclei identified by a nuclear stain (blue).
Strong gradient of mesenchymal marker expression in 3D
It is well-established that the organization of surface-attached cancer cells is very different from the organization in a dense tumor-like structure, i.e., a spheroid. Therefore, we grew glioma spheroids by seeding 500 cells in a U-formed well coated with a covalently bound hydrogel layer to inhibit cell attachments and incubated them for 3 days before fixing and staining. For imaging we used a two-laser LSM, where vim were co-stained with nuclear stain (DNA) to compare penetration depth of the stains and better separate the cells in the spheroids. As seen from Fig 3A and the merged channels in Fig 3B (region of interest from Fig 3A), we found high, uniform vim expression on the spheroid surface. One advantage of LSM is that despite the dense spheroid environment, we can still image cells placed several cell layers below the surface without using clearing agents. So even though the maximum intensity projection (Fig 3B) show uniform vim expression on the spheroid surface, the expression along the radial vector is strongly non-uniform. This is seen from the expression levels of DNA and vim versus distance from surface, d, in Fig 3C. Strikingly, vim expression is highly localized to the surface, whilst DNA basal levels are uniform within the spheroid. Furthermore, vim is mainly found close to the nuclear envelope and extend toward the cell periphery, as earlier reported for intermediate filaments in other non-motile tumor cell types [13]. To check that this result is not biased by penetration issues of the antibodies, we tried different reaction times (from 1 hour to 3 hours). We found no obvious differences, so we anticipate that the marker gradients are independent of incubation times. Furthermore, as DNA was stained at low homogeneous levels penetration does not seem to limit at shallow spheroid depths (<100 μm).
A: Natural spheroid formation primary brain cancer (T115) in liquid cell culture. Maximum intensity z-projection of immunofluorescent vim (yellow). B: Merged image of the region of interest in (B) with immunofluorescent vim (yellow) and nuclei stain (blue). C: Radial distribution of vim (yellow) and nuclei stain (DNA, blue) versus the distance from the spheroid’s surface, d, for both cell lines. The full line is the mean immunostain intensities averaged over different spheroids (N = 4), the shaded areas designate one standard deviation, and the grey vertical bar (SURFACE) indicates the roughness of the spheroid’s surface; corresponding to 1–2 cell widths. Inset: Sketch of how the intensity distribution over the radial vector is averaged. Intensities are measured for a rotating radial vector in a 4 μm slice (10 images) of the spheroid (50 μm depth) as detailed in Materials and Methods.
This strong vim gradient fits in a view, where surface cells are most prone to start invasion of the surrounding tissue. One possible mechanism is that it is the interaction with the local environment that induces the phenotypic response.
Mesenchymal marker expression in invading spheroids
To verify the assumption that invasion will initiate from the vim-expressing surface cells, we prepared an invasion assay: 3 days old spheroids were embedded in the mammalian cellular basement matrix Matrigel™ mixed 1:1 with medium. Hereafter, the spheroids where incubated for 24 hours, which allowed them to invade the matrix before fixation and staining.
As the extracellular matrix is a source of high mechanical force, spheroids respond to the mechanotransduction signals by starting invasion of the surrounding matrix, as seen from Fig 4A. When zooming in as done in Fig 4B (region of interest in Fig 4A), we find long finger-like protrusions—extending from the outermost layer of cells—that are highly vim-enforced. In accordance with earlier findings, where vim was found to elongate in parallel with the microtubules network towards focal adhesions in the filopodia [14]. This result fits with the proposed view that the infiltrations arising from brain cancer are formed on the spheroid surface.
A: Initiation of invasion for glioblastoma U87 in a brain-mimicking matrix. Maximum intensity z-projection of immunofluorescent vim (yellow).B: Merged image of the region of interest in (B) with immunofluorescent vim (yellow) and nuclei stain (blue).
Discussion
As glioblastomas are of mesenchymal origin, their dominant intermediate filament is the cytoskeleton structural protein (vim) [15–17], which is associated with increased proliferation and invasion [8]. Even though xenograft glioblastoma cells (T115) is naturally differentiated and with subpopulations of different characteristics, we found vim to be homogeneously over-expressed on the spheroid surface. In contrast, previous studies have shown that ephitelial cadherin (E-cad) is rarely expressed in glioma cells [6, 15, 18]. Very interestingly, there are also other experimental evidence that the expression levels of the mesenchymal markers are higher at the rim of a spheroid compared to the shielded interior and vice-versa for epithelial markers [19, 20].
When embedded in an extracellular matrix, the cells on the proliferating surface begun invasion by long finger-like protrusions, which is a sign of collective migratory behavior through gained motility and retained cell-cell adhesion [4]. This is in accordance with earlier findings for similar spheroids (U87) [3, 21–23] as well as for other glioblastoma spheroids [3], glioma spheroids [24] etc. Taking these results together, invasion of the micro-environment is initiated from the tumors’ surface cells. We speculate that when the first cells leave the spheroid surface, they expose the cells underneath, and the transition will be triggered to reinforce the cytoskeleton and infiltrate the surroundings.
This infiltrating nature makes it fairly difficult to remove all cancerous tissue by surgery, thus leading to tumor recurrence from margins of resection cavities. Furthermore, various therapies promote infiltration through the expression of growth factors and enrichment of neural and glioma stem cells [25, 26]. It is therefore particularly important for our understanding of brain cancer therapy resistance to unravel the mechanism of infiltrating growth.
Supporting information
S1 File. Step-by-step protocol, also available on protocols.io.
https://doi.org/10.1371/journal.pone.0281161.s001
(PDF)
References
- 1. Gole B, Beatriz M, Alonso D, Dolenc V, Lah T. Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitro. Pathology & Oncology Research. 2009;15:711.
- 2. Weiswald LB, Guinebretière JM, Richon S, Bellet D, Saubaméa B, Dangles-Marie V, et al. In situ protein expression in tumour spheres: development of an immunostaining protocol for confocal microscopy. BMC Cancer. 2010;10(1):106. pmid:20307308
- 3. Vinci M, Gowan S, Boxall F, Patterson L, Zimmermann M, Court W, et al. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biology. 2012;10(1):29. pmid:22439642
- 4. Jolly MK, Boareto M, Huang B, Jia D, Lu M, Ben-Jacob E, et al. Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis. Frontiers in oncology. 2015;5(July):155. pmid:26258068
- 5. Hu B, Wang Q, Wang YA, Hua S, Sauvé CEG, Ong D, et al. Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth. Cell. 2016;167(5):1281–1295. pmid:27863244
- 6. Iwadate Y, Weiswald LLB, Guinebretière JM, Richon S, Bellet D, Saubaméa B, et al. Epithelial-mesenchymal transition in glioblastoma progression. Oncology Letters. 2010;7(3):1615–1620.
- 7.
Cooper GM, Hausman RE. The cell: A molecular approach. 3rd ed. Washington, D.C.: Sunderland, MA: Sinauer Associates; 2004. Available from: http://www.loc.gov/catdir/toc/fy038/2003008953.html.
- 8. Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cellular and Molecular Life Sciences. 2011;68(18):3033–3046. pmid:21637948
- 9. Leduc C, Etienne-Manneville S. Intermediate filaments in cell migration and invasion: The unusual suspects. Current Opinion in Cell Biology. 2015;32:102–112. pmid:25660489
- 10. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: An open-source platform for biological-image analysis. Nature Methods. 2012;9(7):676–682. pmid:22743772
- 11. Niora M, Pedersbæk D, Münter R, Weywadt MFDV, Farhangibarooji Y, Andresen TL, et al. Head-to-Head Comparison of the Penetration Efficiency of Lipid-Based Nanoparticles into Tumor Spheroids. ACS Omega. 2020;5(33):21162–21171. pmid:32875252
- 12. Lin J, Teo S, Lam DH, Jeyaseelan K, Wang S. MicroRNA-10b pleiotropically regulates invasion, angiogenicity and apoptosis of tumor cells resembling mesenchymal subtype of glioblastoma multiforme. Cell Death and Disease. 2012;3(10):398–12. pmid:23034333
- 13. Helfand BT, Mendez MG, Murthy SNP, Shumaker DK, Grin B, Mahammad S, et al. Vimentin organization modulates the formation of lamellipodia. Molecular Biology of the Cell. 2011;22(8):1274–1289. pmid:21346197
- 14. Menko AS, Bleaken BM, Libowitz AA, Zhang L, Stepp MA, Walker JL. A central role for vimentin in regulating repair function during healing of the lens epithelium. Molecular Biology of the Cell. 2014;25(6):776–790. pmid:24478454
- 15. Kubelt C, Hattermann K, Sebens S, Mehdorn HM, Held-Feindt J. Epithelial-to-mesenchymal transition in paired human primary and recurrent glioblastomas. International Journal of Oncology. 2015;46(6):2515–2525. pmid:25845427
- 16. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006;9(3):157–173. pmid:16530701
- 17. Rutka JT, Ivanchuk S, Mondal S, Taylor M, Sakai K, Dirks P, et al. Co-expression of nestin and vimentin intermediate filaments in invasive human astrocytoma cells. International Journal of Developmental Neuroscience. 1999;17(5-6):503–515. pmid:10571412
- 18. Lu Z, Ghosh S, Wang Z, Hunter T. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of β-catenin, and enhanced tumor cell invasion. Cancer Cell. 2003;4(6):499–515. pmid:14706341
- 19. Harner-Foreman N, Vadakekolathu J, Laversin SA, Mathieu MG, Reeder S, Pockley AG, et al. A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristics. Scientific Reports. 2017;7(February). pmid:28094783
- 20. Jeevan DS, Cooper JB, Braun A, Murali R, Jhanwar-Uniyal M. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis. Anticancer Research. 2016;36(2):523–32. pmid:26851006
- 21. Oraiopoulou ME, Tzamali E, Tzedakis G, Liapis E, Zacharakis G, Vakis A, et al. Integrating in vitro experiments with in silico approaches for Glioblastoma invasion: the role of cell-to-cell adhesion heterogeneity. Scientific Reports. 2018;8(1):16200. pmid:30385804
- 22. Nousi A, Søgaard MT, Audoin M, Jauffred L. Single-cell tracking reveals super-spreading brain cancer cells with high persistence. Biochemistry and Biophysics Reports. 2021;28:101120. pmid:34541340
- 23. Audoin M, Søgaard MT, Jauffred L. Tumor spheroids accelerate persistently invading cancer cells. bioRxiv. 2022; p. 1–10. pmid:36038698
- 24. Merz C, Strecker A, Sykora J, Hill O, Fricke H, Angel P, et al. Neutralization of the CD95 ligand by APG101 inhibits invasion of glioma cells in vitro. Anti-cancer Drugs. 2015;26(7):716. pmid:25850884
- 25. Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB, et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Research. 2006;66(16):7843–7848. pmid:16912155
- 26. Hamerlik P, Lathia JD, Rasmussen R, Wu Q, Bartkova J, Lee M, et al. Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth. The Journal of experimental medicine. 2012;209(3):507–20. pmid:22393126